ImmixBio Announces Helen C. Adams Joins Board of Directors

LOS ANGELES: LOS ANGELES, July 13, 2021 /PRNewswire/ -- Immix Biopharma, Inc. ("ImmixBio"), a biotechnology company pioneering Tissue-Specific Therapeutics (TSTx)™ for oncology and inflammation, today announced that accounting and financial expert Helen C. Adams, CFA has joined the Company's Board of Directors. "I am thrilled to welcome Ms. Adams to...

Click to view original post